The pharmaceutical industry is rapidly evolving, with increasing demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, stands as example of this trend. To address https://social-medialink.com/story5494277/leading-us-based-dulaglutide-api-manufacturing-services